BRD3 bromodomain 2 (human, recom

Confirm delete?

BRD3 bromodomain 2 (human, recombinant)

Zoom

Cat No: 14658

Proteins - More Proteins

Key Features Cayman’s BRD3 bromodomain 2 TR-FRET Assay Kit (Item No. 600640) was developed using BRD3 bromodomain 2 (human recombinant) protein.Bulk sizes available upon request The acetylation of histone lysine residues plays a crucial role in the e...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

recombinant proteins genes regulations epigenetics chromatins research cancers BRD3 expressions histones acetylation bromodomains BRDs BRD2 BRD 2 BRD-2 BRD 3 BRD-3 BRD4 BRD 4 BRD-4 BRDT BRD-T RING3-like H4-K5 H4K-5 H-4K5 4K12 K12 4K14 K14 C2-C12 BRD3NUT

Product Overview:
Key Features Cayman’s BRD3 bromodomain 2 TR-FRET Assay Kit (Item No. 600640) was developed using BRD3 bromodomain 2 (human recombinant) protein.Bulk sizes available upon request The acetylation of histone lysine residues plays a crucial role in the epigenetic regulation of gene transcription. Acetylated lysine residues are recognized by a small protein domain known as a bromodomain.{19952} These domains function in the linking of protein complexes to acetylated nucleosomes, thereby controlling chromatin structure and gene expression. The tandem Bromodomains and an Extra Terminal (BET) family of proteins include BRD2, BRD3, BRD4, and BRDT.{19953} The BET proteins play a key role in many cellular processes, including inflammatory gene expression, mitosis, and viral/host interactions.{19559,19558,19930} The isolated individual or tandem bromodomains of BRD3 have been shown to bind acetylated histone tails serving to couple histone acetylation marks to the transcriptional regulation of target promoters.{19959,19960,19961,19962,19558} Small molecule inhibitors of these interactions hold promise as useful therapeutics for human disease.{19044,19929,19950} This protein product contains the second bromodomain region of BRD3.

Size	100 µg
Shipping	dry ice
Formulation	50 mM Tris, pH 7.5, containing 150 mM sodium chloride and 20% glycerol
Purity	≥95% estimated by SDS-PAGE
Custom Code	3504.00
UNSPSC code	12352204

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.